In this system, GM-CSF–loaded OMVs primed bone marrow progenitors and monocytes, which were later recruited to the tumour site by tumour-associated macrophages (TAMs), while SIRPα-Fc–modified OMVs improved TAM-mediated phagocytosis [98]. Here, CSF2 is linked to neoplasm.